NATCO Pharma Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 11,405 million compared to INR 8,846 million a year ago. Revenue was INR 11,602 million compared to INR 9,189 million a year ago.

Net income was INR 4,203 million compared to INR 3,204 million a year ago. Basic earnings per share from continuing operations was INR 23.26 compared to INR 17.55 a year ago. Diluted earnings per share from continuing operations was INR 23.26 compared to INR 17.55 a year ago.